Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain-derived neurotrophic factor and schizophrenia
Pasquale Di Carlo, Giovanna Punzi, Gianluca Ursini
Psychiatric Genetics (2019) Vol. 29, Iss. 5, pp. 200-210
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
Anna Pisani, Fabiola Paciello, V. Del Vecchio, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 4, pp. 652-652
Open Access | Times Cited: 44
Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases
María Teresa Flores-Dorantes, Yael E. Díaz‐López, Ruth Gutiérrez‐Aguilar
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 109
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception
Natalia Cappoli, Elisabetta Tabolacci, Paola Aceto, et al.
Journal of Neuroimmunology (2020) Vol. 349, pp. 577406-577406
Closed Access | Times Cited: 97
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Rodrigo Nieto, Andrea Carrasco, Sebastián Corral, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 64
Can epigenetics shine a light on the biological pathways underlying major mental disorders?
Luis Alameda, Giulia Trotta, Harriet Quigley, et al.
Psychological Medicine (2022) Vol. 52, Iss. 9, pp. 1645-1665
Open Access | Times Cited: 44
BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
Amjad H. Bazzari, Firas H. Bazzari
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8417-8417
Open Access | Times Cited: 40
Maternal immune activation and role of placenta in the prenatal programming of neurodevelopmental disorders
Rebecca M. Woods, Jarred M. Lorusso, Jennifer Fletcher, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 27
New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism
Carlye Szarowicz, Kathy Steece‐Collier, Margaret E. Caulfield
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8011-8011
Open Access | Times Cited: 34
Brain-derived neurotrophic factor (BDNF) epigenomic modifications and brain-related phenotypes in humans: A systematic review
Amery Treble‐Barna, Lacey W. Heinsberg, Zachary Stec, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 147, pp. 105078-105078
Open Access | Times Cited: 20
Diverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters
He You, Bai Lu
Biomolecules (2023) Vol. 13, Iss. 4, pp. 655-655
Open Access | Times Cited: 20
Prioritization of potential causative genes for schizophrenia in placenta
Gianluca Ursini, Pasquale Di Carlo, Sreya Mukherjee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential
Anam N. Khan, Rahul D. Jawarkar, Magdi E. A. Zaki, et al.
Nutritional Neuroscience (2024) Vol. 27, Iss. 11, pp. 1306-1320
Closed Access | Times Cited: 6
Protective effect of irisin against Alzheimer’s disease
Kang Chen, Kun Wang, Tianhui Wang
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 25
Integrated 16S rRNA gene sequencing and LC/MS-based metabolomics ascertained synergistic influences of the combination of acupuncture and NaoMaiTong on ischemic stroke
Minghua Xian, Lin Shen, Sikai Zhan, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115281-115281
Open Access | Times Cited: 24
Natural compound targeting BDNF V66M variant: insights from in silico docking and molecular analysis
Azra Sakhawat, Muhammad Umer Khan, Raima Rehman, et al.
AMB Express (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Antidepressant Effects of Essential Oils: A Review of the Past Decade (2012–2022) and Molecular Docking Study of Their Major Chemical Components
Emily Christie M. Fonseca, Lanalice R. Ferreira, Pablo Luis B. Figueiredo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9244-9244
Open Access | Times Cited: 13
Neurotrophins and Their Receptors: BDNF’s Role in GABAergic Neurodevelopment and Disease
Carlos Cano, Natalia Varela-Andrés, Alejandro Cebrián-León, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8312-8312
Open Access | Times Cited: 5
Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders
Maren Caroline Frogner Werner, Katrine V. Wirgenes, Marit Haram, et al.
Schizophrenia Research (2020) Vol. 218, pp. 55-62
Open Access | Times Cited: 37
GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome
Ferdinando Bonfiglio, Xingrong Liu, Christopher S. Smillie, et al.
Cell Genomics (2021) Vol. 1, Iss. 3, pp. 100069-100069
Open Access | Times Cited: 28
The Rohingya refugees: a conceptual framework of their psychosocial adversities, cultural idioms of distress and social suffering
Nivedita Sudheer, Debanjan Banerjee
Cambridge Prisms Global Mental Health (2021) Vol. 8
Open Access | Times Cited: 28
Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies
Michael Camilleri, Alexandra Zhernakova, Isotta Bozzarelli, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 11, pp. 689-702
Closed Access | Times Cited: 22
Fucoidan ameliorates LPS-induced neuronal cell damage and cognitive impairment in mice
Yingying Wang, Qianqian Wang, Linyan Duan, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 759-771
Closed Access | Times Cited: 19
BDNF and GSK-3beta expression changes underlie the beneficial effects of crocin on behavioral alterations in a rat model of autism induced by prenatal valproic acid administration
Seyedeh-Fatemeh Hosseini, Maryam Ghadimi, Niloufar Reyhani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review
Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
NGF-β and BDNF levels are altered in male patients with chronic schizophrenia: effects on clinical symptoms
Haidong Yang, Qing Tian, Lingshu Luan, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top